Soft Tissue Leiomyosarcoma With Microsatellite Instability, High Tumor Mutational Burden, and Programmed Death Ligand-1 Expression Showing Pathologic Complete Response to Pembrolizumab: A Case Report

JCO Precis Oncol. 2022 Jul:6:e2200068. doi: 10.1200/PO.22.00068.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen / genetics
  • Humans
  • Leiomyosarcoma* / drug therapy
  • Microsatellite Instability*

Substances

  • Antibodies, Monoclonal, Humanized
  • B7-H1 Antigen
  • CD274 protein, human
  • pembrolizumab